(Q34035333)

English

Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

0 references

0 references

Low-dose naltrexone

0 references

author name string

Jarred Younger

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Noorulain Noor

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Rebecca McCue

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sean Mackey

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

529-538

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Low-dose naltrexone therapy improves active Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Low-dose naltrexone for pruritus in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Low-dose naltrexone for disease prevention and quality of life

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

The multifaceted profile of activated microglia.

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Physiology of microglia

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

The prevalence and characteristics of fibromyalgia in the general population.

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Central sensitization: implications for the diagnosis and treatment of pain

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Development of responder definitions for fibromyalgia clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Fatigue is associated with high circulating leptin levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Effects of leptin on the production of cytokines by cultured human endometrial stromal and epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Chemokines as pain mediators and modulators

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Chemokines and the pathophysiology of neuropathic pain

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Chemokines and pain mechanisms.

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Chronic opioid antagonist treatment dose-dependently regulates mu-opioid receptors and trafficking proteins in vivo

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Decreased central mu-opioid receptor availability in fibromyalgia.

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

The temporal dynamics of poststroke neuroinflammation: a longitudinal diffusion tensor imaging-guided PET study with 11C-PK11195 in acute subcortical stroke

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

A novel inhibitory effect of naloxone on macrophage activation and atherosclerosis formation in mice.

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway.

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

A systematic review of adverse events in placebo groups of anti-migraine clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia

1 reference

https://api.crossref.org/works/10.1002%2FART.37734

21 January 2018

Identifiers

10.1002/ART.37734

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34035333&oldid=1947982637"